Overview

• U.S. home care provider's Q1 revenue rose 15.9%, beating analyst expectations

• Adjusted net income per diluted share nearly doubled from a year ago

• Company raised full-year 2026 revenue and adjusted EBITDA guidance

Outlook

• Aveanna Healthcare raises full-year 2026 revenue guidance to $2.56-$2.58 bln

• Company lifts full-year 2026 adjusted EBITDA forecast to $328-$332 mln

• Aveanna says guidance excludes pending Family First Homecare acquisition

Result Drivers

• SEGMENT GROWTH - Revenue gains were driven by increases across all business segments, led by a $75.7 mln rise in Pediatric Day Services (PDS), with additional growth in Home Health & Hospice and Medical Solutions

• STRATEGIC INITIATIVES - Co cited Preferred Payor and Government Affairs strategies as underpinning continued growth across all business segments, per CEO Jeff Shaner

• ORGANIC GROWTH FOCUS - Co said focus remains on delivering strong organic growth across Aveanna’s national footprint while awaiting regulatory approval for the Family First Homecare transaction

Company press release: ID:nGNX2ZyZj7

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q1 Revenue	Beat	$647.90 mln	$613.19 mln (10 Analysts)
Q1 EPS		$0.19
Q1 Net Income		$41.70 mln
Q1 Adjusted EBITDA		$84.40 mln

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the healthcare facilities & services peer group is "buy"

• Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $10.00, about 47.7% above its May 13 closing price of $6.77

• The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.